How to Use Pasireotide
Complete guide to Pasireotide dosing, administration, timing, and protocol recommendations.
Quick Overview
Pasireotide (brand name Signifor) is a second-generation somatostatin analog, a cyclic six-amino-acid peptide engineered to hit more receptor subtypes than octreotide or lanreotide. Its standout use is Cushing's disease, where it was the first drug FDA-approved (2012) to directly target the pituitary tumor driving cortisol excess, and it is also approved for acromegaly that resists first-line analogs. The catch is real and well known: it raises blood sugar in most patients, so it is a powerful but high-maintenance option.
Dosing Guidelines
Common Dose
300-900 mcg twice daily
Frequency
Twice daily (SC) or monthly (LAR)
Dose Range
300-900 mcg per dose
Note: Somatostatin analog for Cushing's disease. Higher hyperglycemia risk than other somatostatins.
Administration Method
Subcutaneous or intramuscular
Best Time to Take
Morning or as directed
Timing may vary based on individual response and goals. Consistency is generally more important than specific timing.
Protocol Duration
Long-term / chronic use
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Hyperglycemia and diabetes (very common)
- •Diarrhea
- •Nausea
- •Gallstones
- •QT prolongation (serious)
Frequently Asked Questions
What is the recommended dose for Pasireotide?
300-900 mcg twice daily
How do you administer Pasireotide?
Subcutaneous or intramuscular
When is the best time to take Pasireotide?
Morning or as directed
How long should you use Pasireotide?
Long-term / chronic use
This information is for educational purposes only. Always consult with a healthcare professional before using any peptide. Dosing information is based on research literature and community reports, not medical advice.